Northway Biotech Inc

Alkermes is a worldwide pharmaceutical company that develops controlled, sustained-release injectable drugs using with its trademark ProLease and Medisorb technologies. Located in Massachusetts, the company also develops inhaled formulations from its proprietary pulmonary technology. Alkermes has partnered with Johnson & Johnson to develop Riserpdal Consta, an antipsychotic drug used in the treatment of schizophrenia. Risperdal Consta is approved for sale in more than 50 countries that include the United States, United Kingdom and Germany. In addition to a host of partnered products, the ocmpany is also active in the development of several promising proprietary products, such as Vivitrex, a long-acting injectable form of naltrexone for alcohol dependence. Alkermes is headquartered in Cambridge, Mass.

Upstream Bio, Inc., located in Waltham, MA, is dedicated to addressing inflammation at its source through the development of innovative treatments. The company is advancing verekitug, a clinical-stage monoclonal antibody designed to target an upstream driver of inflammatory responses, aiming to enhance treatment options for patients suffering from severe inflammatory diseases. With a dynamic and experienced team, Upstream Bio focuses on empowering employees while uplifting patients by addressing unmet needs in the field of inflammatory diseases. Their commitment to scientific advancement positions them as a significant player in the pursuit of better health outcomes for millions. Generated from the website

ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.